Table 1 Characteristics of patients according to NLR

Gender (male vs female)

111 vs 19

78 vs 14

NS

Age

52.0 ± 11.3

55.1 ± 10.0

0.049

Albumin (g/L)

41.81 ± 5.13

42.13 ± 4.77

NS

ALT (U/L)

59.88 ± 82.22

64.65 ± 110.44

NS

AST (U/L)

39.25 ± 20.63

54.99 ± 83.46

NS

TB (mg/dL)

0.84 ± 0.34

1.16 ± 1.08

0.012

Cr (mg/dL)

0.87 ± 0.17

0.98 ± 0.78

NS

Lymphocyte counts (10⁹/L)

1.80 ± 0.66

1.20 ± 0.50

<0.001

Neutrophil counts (10⁹/L)

2.59 ± 0.83

4.70 ± 2.61

<0.001

WBC counts (10⁹/L)

4.90 ± 1.45

6.49 ± 2.79

<0.001

HBsAg (positive vs negative)

118 vs 12

72 vs 20

0.011

Anti-HCV (positive vs negative)

1 vs 129

0 vs 92

NS

AFP (ng/mL) (≤20 vs >20)

51 vs 79

40 vs 52

NS

INR

1.02 ± 0.077

1.03 ± 0.09

NS

Platelet counts (10⁹/L)

137.36 ± 57.08

134.16 ± 62.42

NS

Vascular invasion (yes vs no)

25 vs 105

24 vs 68

NS

Tumor differentiation (I–II vs III–IV)

94 vs 36

73 vs 19

NS

Tumor encapsulation (yes vs no)

50 vs 80

45 vs 47

NS

Tumor size (≤3.0 vs >3.0)

74 vs 56

40 vs 52

NS

TNM stage (I–II vs IIIA)

108 vs 22

70 vs 22

NS

Postoperative TACE (yes vs no)

37 vs 93

32 vs 60

NS

Re-operation (yes vs no)

10 vs 120

6 vs 86

NS